Rincon Bio performs 786-O xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
Organism: Homo sapiens, human / Tissue: kidney / Disease: renal cell adenocarcinoma
786-O cells were derived from a 58 year old male caucasian with a primary clear cell adenocarcinoma
Used in xenografts to test the efficacy of novel cancer therapeutics. Tumors develop after being injected into the flank of immunocompromised mice.
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients! We are flexible and easy to work with. And we take a personal interest in our clients' studies.